Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

AstraZeneca concludes Alexion acquisition for $39bn

pharmaceutical-technologyJuly 23, 2021

Tag: AstraZeneca , Alexion , acquisition

PharmaSources Customer Service